The CAPRISA clinical trials : HIV treatment and prevention /
Saved in:
Imprint: | Cham, Switzerland : Springer, 2017. |
---|---|
Description: | 1 online resource |
Language: | English |
Subject: | |
Format: | E-Resource Book |
URL for this record: | http://pi.lib.uchicago.edu/1001/cat/bib/11271175 |
Table of Contents:
- Part I. Introduction
- Studies Linked to the Evolving HIV Epidemic in South Africa: Informing the CAPRISA Scientific Agenda
- CAPRISA: Establishing A Research Center to Undertake HIV Clinical Trials
- Overview of Clinical Trials
- Part II. CAPRISA Clinical Trials for HIV and HSV-2 Prevention
- Antiretrovirals for HIV Prevention
- Rolling out of tenofovir gel in family planning clinics: the CAPRISA 008 implementation trial
- Conditional cash transfers to reduce HIV risk in young women: the CAPRISA 007 cluster randomised control trial
- HIV vaccine and passive immunity trials
- Part III: CAPRISA Clinical Trials for HIV?TB Treatment
- CAPRISA 003: Timing of antiretroviral initiation in HIV-TB co-infected patients
- The SAPiT Trial
- Scaling up TB-HIV integration in public health clinics: translating research findings into practice
- Part IV: Experiences and lessons learnt from clinical trials in CAPRISA
- Lessons from the Acute Infection Study: from Bench to Bedside
- Understanding sexual HIV transmission in women by focusing on the genital mucosa
- Part V: Essential support activities for the conduct of clinical trials
- Good practices in conducting clinical trials: Good Participatory Practice, Good Pharmacy Practice and Good Laboratory Practice
- Grants Management
- Taking science to the people: communication and media strategies for clinical trials
- Looking ahead: What Does the Future Hold for CAPRISA?
- Appendix
- Index.